Premium
Maximizing the Clinical Utility of Comparative Effectiveness Research
Author(s) -
Umscheid C A
Publication year - 2010
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1038/clpt.2010.200
Subject(s) - comparative effectiveness research , clinical pharmacology , management science , clinical effectiveness , clinical decision making , actuarial science , medicine , alternative medicine , business , intensive care medicine , economics , pharmacology , pathology
Providers, consumers, payers, and policy makers are awash in choices when it comes to medical decision making and need better evidence to inform their decisions. Large federal investments in comparative effectiveness research (CER) aim to fill this need. But how do we ensure the clinical utility of CER? Here, I define comparative effectiveness and clinical utility, outline metrics to evaluate clinical utility, and suggest methods for maximizing the clinical utility of CER for the various stakeholders. Clinical Pharmacology & Therapeutics (2010) 88 6, 876–879. doi: 10.1038/clpt.2010.200